|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Accounts receivable, net - related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts receivable, net - related parties | ||||||||||||||||||||
| Advances to suppliers | ||||||||||||||||||||
| Amount due from related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total amount due from related parties | ||||||||||||||||||||
| Prepayments | ||||||||||||||||||||
| Deferred expenses | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepayments and other receivables | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Construction in progress | ||||||||||||||||||||
| NON-CURRENT ASSETS | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Equipment and vehicles, net | ||||||||||||||||||||
| Long term deferred expenses | ||||||||||||||||||||
| Deposits for capital leases | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Short-term loans | ||||||||||||||||||||
| Long-term loans due within one year | ||||||||||||||||||||
| Accounts payable, trade | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Deposits received | ||||||||||||||||||||
| Accounts payable, trade-related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable, trade-related parties | ||||||||||||||||||||
| Advances from customers | ||||||||||||||||||||
| Amount due to related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total amount due to related parties | ||||||||||||||||||||
| Deferred tax payable | ||||||||||||||||||||
| Payroll payable | ||||||||||||||||||||
| Lease liabilities - current | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Taxes payable | ||||||||||||||||||||
| Other payables and accrued liabilities | ||||||||||||||||||||
| Finance lease liabilities, current | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Lease liabilities – non-current | ||||||||||||||||||||
| Deferred tax payable | ||||||||||||||||||||
| Other capital lease payable | ||||||||||||||||||||
| Non-current liabilities of discontinued operations | ||||||||||||||||||||
| Long-term loans - noncurrent portion | ||||||||||||||||||||
| Long-term loans - noncurrent portion | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Common stock, $0.0001 par value; 100,000,000 shares authorized; 84,598,650 and 82,594,105 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total JRSIS HEALTH CARE CORPORATION’s equity | ||||||||||||||||||||
| NONCONTROLLING INTERESTS | ||||||||||||||||||||
| TOTAL EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND EQUITY | ||||||||||||||||||||
Loading...
